酒精作为阿尔茨海默病的可修改风险因素 - - 来自实验研究的证据
Devaraj V Chandrashekar1, Ross A Steinberg2, Derick Han2
1Department of Biomedical and Pharmaceutical Sciences, School of Pharmacy, Chapman University, Irvine, CA 92618, USA.
International journal of molecular sciences
|June 10, 2023
概括
过度饮酒会恶化阿尔茨海默病 (AD) 病理,而低摄入量可能有保护作用. 本审查审查了证据和机制,包括肝损伤,将酒精与AD进展或预防联系起来.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特征是认知能力下降.
- 关于酒精对阿尔茨海默氏症的影响的流行病学数据是相互矛盾的,有些人认为大量饮酒的危害和低摄入量的潜在益处.
- 方法上的差异有助于围绕酒精在阿尔茨海默病中的作用的争议.
研究的目的:
- 审查关于酒精消费如何影响阿尔茨海默病 (AD) 病理学的实验证据.
- 总结一下建议的机制,无论是中央还是肝脏,酒精可以促进或防止AD进展.
主要方法:
- 发表的实验研究的审查,包括细胞培养和AD的动物模型.
- 在AD小鼠模型中对酒精养研究的分析.
- 检查涉及酒精对大脑和肝脏影响的拟议分子和细胞通路.
主要成果:
- 在AD模型中,高酒精摄入量促进和加速AD病理,特别是在引起肝损伤时.
- 在实验模型中,低剂量的酒精可能会对阿尔茨海默病理产生保护作用.
- 机制包括大脑途径的调节 (例如,Akt/mTOR,Aβ代谢) 和酒精诱导的肝损伤影响大脑Aβ恒温.
结论:
- 酒精对AD的影响是剂量依赖和复杂的,高消费会加剧疾病.
- 酒精诱导的肝损伤在调节大脑病理和Aβ水平方面发挥着重要作用.
- 对具体机制的进一步研究对于了解酒精在阿尔茨海默病中的双重作用至关重要.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.酒精 酒精 酒精 酒精 酒精 酒精 酒精 酒精动物模型动物模型细胞培养培养的细胞培养.肝脏损伤 肝脏损伤是什么?肝脏肥胖症 肝脏肥胖症β-氨基化物是什么?更多相关视频
09:26Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
18.8K
19:57The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Published on: August 5, 2017
8.5K
相关概念视频
Alzheimer's Disease: Overview
532
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
532
Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223
CNS Depressants: Alcohol and Nicotine
287
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
287
